Every night, the online Belgian patent register ('eRegister') receives an update with public data that were entered or generated the preceding day on the Benelux Patent Platform, the computer application with which the Belgian Intellectual Property Office handles the registration, treatment and publication processes for patents and supplementary protection certificates.
Currently, some updates are spread over consecutive nights due to the large, weekly volume of data concerning European patents designating Belgium.
For a European patent it is possible that data about the inventor(s) are missing from the online Belgian patent register. They can be found via the link to the European patent register pending an update of the Belgian patent register.
For European patents with Unitary Effect, the authentic source of information is the European Patent Register : please refer to it.

Patent details

1237888 Title: BIPHENYL SULFONAMIDES UTILISES COMME DOUBLES ANTAGONISTES DES RECEPTEURS DE L'ANGIOTENSINE ET DE L'ENDOTHELINE

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic information

Application number:
009842824
WO application number:
US2000033730
Type:
European patent granted for BE
Status:
Publication number:
1237888
WO publication number:
WO 2001/044239
1rst applicant's nationality:
Translation language:
EPO publication language:
English
SPC number:

Dates

Filing date:
13/12/2000
Grant date:
13/09/2006
EP publication date:
WO publication date:
Claims translation received date:
Translation received date (EP publication B1):
Translation received date (EP publication B2):
Translation received date (EP publication B3):
Registration date:
EP B1 publication date:
13/09/2006
EP B2 publication date:
EP B3 publication date:
Lapsed date:
Expiration date (if granted and all annual fees paid):

Applicant

Name:
Bristol-Myers Squibb Company
Legal Form:
From:
13/09/2006
Address:
P.O. Box 4000 Lawrenceville-Princeton Road Princeton NJ 08543-4000(US), US
To:

Priority

1

Priority patent number:
464037
Priority date:
15/12/1999
Priority country:
United States (US)

2

Priority patent number:
481197
Priority date:
11/01/2000
Priority country:
United States (US)

3

Priority patent number:
513779
Priority date:
25/02/2000
Priority country:
United States (US)

4

Priority patent number:
604322
Priority date:
26/06/2000
Priority country:
United States (US)

5

Priority patent number:
643640
Priority date:
22/08/2000
Priority country:
United States (US)

Classification

IPC or IDT classification:
C07D 413/12 ; C07D 413/14 ; C07D 403/14 ; C07D 487/04 ; C07D 261/16 ; C07D 401/12 ; C07D 417/12 ; A61K 31/42 ; A61P 9/12;

Additional information section

Status:
ZONDER GEVOLG / SANS EFFET
Case kind / Max duration / Publication code:
Basic patent details (Patent law 1854):
Representative details:
Inventor(s) details:
MURUGESAN, Natesan;TELLEW, John, E.;MACOR, John, E.;GU, Zhengxiang;
History of owners:
Filing date Document type Publication Type Document Description Number of pages File Type